Skip to main content

FULL MENUFULL MENU Presented by

Career

Check out the December issue of GI&Hepatology News

Error message

Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

Conference Coverage

Rivaroxaban bonus: Early unmasking of occult GI cancers

Publish date: September 22, 2018

REPORTING FROM THE ESC CONGRESS 2018

bjancin@mdedge.com

Pages

« first
1
2
3
4
5

Next Article:

First reversal agent for apixaban and rivaroxaban gets fast-track approval

GI Oncology

More GI Oncology News

Pancreatic cystic neoplasms rarely turn cancerous, study shows
Meta-analysis of postcancer use of immunosuppressive therapies shows no increase in cancer recurrence risk
Microsimulation model identifies 4-year window for pancreatic cancer screening
Many preoperative EAC biopsies fail to predict true tumor grade, leading to unnecessary esophagectomy
Report cards, additional observer improve adenoma detection rate
Two multitarget stool tests show promise for CRC screening: Studies
AGA issues CPU for CRC screening, postpolypectomy surveillance
Gastroenterology Data Trends 2023

Management of malignant alimentary tract obstruction

Question 1 of 4

In colorectal cancer patients with esophageal obstruction who ____ eligible for resection, the use of self-expanding metal stents (SEMS) ____ recommended.

Choose one

	are not; is not
	are; is
	are; is not

This Publication

About Us
Advertise
Board of Editors
Contact Us
Corporate Management
Editorial Staff
Resources
Editorial Calendar
Subscribe to GI and Hepatology News

Facebook
Twitter

Specialty Focus

IBD & Intestinal Disorders
Liver Disease
GI Oncology

Top Sections

From the AGA Journals
Conference Coverage
News from the AGA

Highlighted from this site and network

Contact ClinicalEdge Manager
Contact MD-IQ Manager
GI Career Search

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

FULL MENU FULL MENU

FULL MENU FULL MENU

Explore

Explore